+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Sodium Hyaluronate-based Products Market Size, Share & Trends Analysis Report by Type (Injectable, Topical), Application {Pharmaceuticals (Orthopedic, Ophthalmology, Urology), Cosmetics}, Region, and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 120 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 5450256
Description Jump to:
The global sodium hyaluronate-based products market size is expected to reach USD 17.73 billion by 2030, registering a CAGR of 7.7% from 2023 to 2030, according to the report. The market growth is attributed to factors such as the increasing geriatric population, a high prevalence of osteoarthritis and cataracts, technological advancements, rising awareness, and a growing number of non-invasive aesthetic procedures globally.

The demand for antiaging cosmetics and aesthetic treatments, which help people in reversing their aging signs, is increasing, mainly due to a global increase in the aging population. Sodium hyaluronate (NaHA) is more soluble than hyaluronic acid, along with having smaller molecules and greater skin penetration. It is increasingly being used in dermal fillers that are injected into areas of the skin to fill out wrinkles and help restore a more youthful appearance. Some of the FDA-approved sodium hyaluronate dermal fillers available in the market are Restylane Defyne, Refyne, and Restylane. Thus, it is anticipated that the need for such products will act as a high-impact rendering driver for sodium hyaluronate-based products over the forecast period.

The WHO predicts that by 2050, an estimated 15% of the world’s population above the age of 60 years will suffer from symptomatic osteoarthritis. Along with the aging population, an increase in other risk factors such as obesity and a sedentary lifestyle is expected to further exacerbate the problem. Due to the aforementioned factors and the effectiveness of sodium hyaluronate products in treating these conditions, its market is expected to grow significantly over the forecast period.

Although sodium hyaluronate-based products offer major benefits, due to their expensive nature, they can be out of reach for certain patient groups. For instance, the average price of NaHA injections in the U.S. ranges from USD 350 to USD 800. Moreover, benefits derived from sodium hyaluronate dermal fillers are temporary, lasting up to 18 months and requiring further upkeep treatments to maintain the desired effect, leading to additional expenses. Single-phase products and duplex products of hyaluronic acid are premium-priced products, and thus, they are not accessible to all patients. Their high price primarily reflects high manufacturing costs.

Moreover, the SARS-CoV-2 pandemic has substantially impacted the sodium hyaluronate market. A decrease in the number of surgical procedures worldwide and disruptions in the supply chain have reduced the demand for sodium hyaluronate-based products worldwide.

Key players are leveraging multiple strategies such as new product launches and strategic partnerships to expand their product portfolio, and thereby, have a more competitive range of offerings. For instance, in 2020, Seikagaku Corporation and Eisai Co., Ltd. formed a marketing alliance for SI-613 (diclofenac-conjugated sodium hyaluronate) in South Korea. Based on this agreement, Eisai Korea, Inc. will be the exclusive distributor of SI-613 in South Korea.

Sodium Hyaluronate-based Products Market Report Highlights

  • The injectable segment accounted for the largest revenue share of over 90% in 2022 owing to a wide range of applications, such as dermal fillers in cosmetic procedures, pain relief in osteoarthritis, surgical aids in cataract extractions, and anti-adhesives in gynecological operations
  • The pharmaceutical segment held the largest revenue share of over 60% in 2022 and is anticipated to grow at the fastest CAGR of 7.9% over the forecast period owing to the high usage in a variety of pharmaceutical applications
  • North America dominated the market and accounted for the largest revenue share of over 35% in 2022 due to the higher healthcare expenditure and a greater number of cataract and dermal filler procedures as compared to other regions


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Microneedle Drug Delivery Systems Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Sodium Hyaluronate - Based Products Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Sodium Hyaluronate-Based Products: Type Estimates & Trend Analysis
4.1. Sodium Hyaluronate-Based Products Market: Key Takeaways
4.2. Sodium Hyaluronate-Based Products Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Topical
4.3.1. Topical market estimates and forecast, 2018 - 2030 (USD Million)
4.4. Injectable
4.4.1. Injectable market estimates and forecast, 2018 - 2030 (USD Million)
4.5. Others
4.5.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. Sodium Hyaluronate-Based Products: Applications Estimates & Trend Analysis
5.1. Sodium Hyaluronate-Based Products Market: Key Takeaways
5.2. Sodium Hyaluronate-Based Products Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Pharmaceuticals
5.3.1. Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
5.3.1.1. Ophthalmic
5.3.1.1.1. Ophthalmic market estimates and forecast, 2018 - 2030 (USD Million)
5.3.1.2. Orthopedic
5.3.1.2.1. Ophthalmic market estimates and forecast, 2018 - 2030 (USD Million)
5.3.1.3. Urology
5.3.1.3.1. Urology market estimates and forecast, 2018 - 2030 (USD Million)
5.3.1.4. Others
5.3.1.4.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
5.4. Cosmetics
5.4.1. Cosmetics market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Sodium Hyaluronate-Based Products: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Sodium Hyaluronate-Based Products: Key Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. Allergan, Inc.(a part of AbbVie, Inc.)
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Galderma S.A.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Bohus BioTech AB
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. LG Chem Ltd.
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Syner-Med (Pharmaceutical Products) Ltd.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Anika Therpeutics Inc.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Cadila Pharmaceuticals Ltd.
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Ferring Pharmaceuticals B.V.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Fidia Farmaceutici S.p.A.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 3 North America sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
Table 4 U.S. sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 5 U.S. sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 6 Canada sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 7 Canada sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 8 Europe sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 9 Europe sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 10 Europe sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
Table 11 Germany sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 12 Germany sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 13 UK sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 14 UK sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 15 France sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 16 France sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 17 Italy sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 18 Italy sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 19 Spain sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 20 Spain sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 21 Sweden sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 22 Sweden sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 23 Norway sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 24 Norway sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 25 Denmark sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 26 Denmark sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 27 Asia Pacific sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 28 Asia Pacific sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 29 Asia Pacific sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
Table 30 China sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 31 China sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 32 Japan sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 33 Japan sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 34 India sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 35 India sodium hyaluronate-based products market, by application, (USD Million) 2018 - 2030
Table 36 Australia sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 37 Australia sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 38 Thailand sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 39 Thailand sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 40 South Korea sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 41 South Korea sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 42 Latin America sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 43 Latin America sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 44 Latin America sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
Table 45 Brazil sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 46 Brazil sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 47 Mexico sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 48 Mexico sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 49 Argentina sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 50 Argentina sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 51 Middle East and Africa sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
Table 54 South Africa sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 55 South Africa sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 56 Saudi Arabia sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 58 UAE sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 59 UAE sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
Table 60 Kuwait sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
Table 61 Kuwait sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Microneedle drug delivery systems: Market outlook
Fig. 9 Microneedle drug delivery systems: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Sodium hyaluronate-based products market driver impact
Fig. 15 Sodium hyaluronate-based products market restraint impact
Fig. 16 Sodium hyaluronate-based products market strategic initiatives analysis
Fig. 17 Sodium hyaluronate-based products market: Type movement analysis
Fig. 18 Sodium hyaluronate-based products market: Type outlook and key takeaways
Fig. 19 Topical market estimates and forecasts, 2018 - 2030
Fig. 20 Injectable market estimates and forecasts, 2018 - 2030
Fig. 21 Others market estimates and forecasts, 2018 - 2030
Fig. 22 Sodium hyaluronate-based products market: Application movement analysis
Fig. 23 Sodium hyaluronate-based products market: Application outlook and key takeaways
Fig. 24 Pharmaceutical market estimates and forecasts, 2018 - 2030
Fig. 25 Cosmetics market estimates and forecasts, 2018 - 2030
Fig. 26 Global sodium hyaluronate-based products market: Regional movement analysis
Fig. 27 Global sodium hyaluronate-based products market: Regional outlook and key takeaways
Fig. 28 North America market estimates and forecasts, 2018 - 2030
Fig. 29 U.S. market estimates and forecasts, 2018 - 2030
Fig. 30 Canada market estimates and forecasts, 2018 - 2030
Fig. 31 Europe market estimates and forecasts, 2018 - 2030
Fig. 32 UK market estimates and forecasts, 2018 - 2030
Fig. 33 Germany market estimates and forecasts, 2018 - 2030
Fig. 34 France market estimates and forecasts, 2018 - 2030
Fig. 35 Italy market estimates and forecasts, 2018 - 2030
Fig. 36 Spain market estimates and forecasts, 2018 - 2030
Fig. 37 Sweden market estimates and forecasts, 2018 - 2030
Fig. 38 Norway market estimates and forecasts, 2018 - 2030
Fig. 39 Denmark market estimates and forecasts, 2018 - 2030
Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 41 Japan market estimates and forecasts, 2018 - 2030
Fig. 42 China market estimates and forecasts, 2018 - 2030
Fig. 43 India market estimates and forecasts, 2018 - 2030
Fig. 44 Australia market estimates and forecasts, 2018 - 2030
Fig. 45 Thailand market estimates and forecasts, 2018 - 2030
Fig. 46 South Korea market estimates and forecasts, 2018 - 2030
Fig. 47 Latin America market estimates and forecasts, 2018 - 2030
Fig. 48 Brazil market estimates and forecasts, 2018 - 2030
Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
Fig. 50 Argentina market estimates and forecasts, 2018 - 2030
Fig. 51 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 53 South Africa market estimates and forecasts, 2018 - 2030
Fig. 54 UAE market estimates and forecasts, 2018 - 2030
Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030

Companies Profiled

  • Allergan, Inc.(a part of AbbVie, Inc.)
  • Galderma S.A.
  • Bohus BioTech AB
  • LG Chem Ltd.
  • Syner-Med (Pharmaceutical Products) Ltd.
  • Anika Therpeutics Inc.
  • Cadila Pharmaceuticals Ltd.
  • Ferring Pharmaceuticals B.V.
  • Fidia Farmaceutici S.p.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedNovember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 9.83 Billion
Forecasted Market Value ( USD ) by 2030 $ 17.73 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Sodium Hyaluronate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Sodium Hyaluronate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 111 Pages
  • Global
From
Sodium Hyaluronate (HA) (CAS 9067-32-7) Global Market Research Report 2024 - Product Image

Sodium Hyaluronate (HA) (CAS 9067-32-7) Global Market Research Report 2024

  • Report
  • 85 Pages
  • Global
From
Hyaluronic Acid Serums Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Hyaluronic Acid Serums Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 300 Pages
  • Global
Osteoarthritis - Market Insight, Epidemiology and Market Forecast - 2032 - Product Image

Osteoarthritis - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • 289 Pages
  • Global
From
Osteoarthritis Global Market Report 2024 - Product Image

Osteoarthritis Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Sodium Hyaluronate Market

Sodium Hyaluronate is a chemical compound derived from hyaluronic acid, a naturally occurring polysaccharide found in the human body. It is widely used in the cosmetics and pharmaceutical industries due to its ability to bind to water and form a protective film on the skin. It is also used in medical treatments such as joint lubrication and wound healing. Sodium Hyaluronate is used in a variety of products, including skin care creams, lotions, and serums, as well as injectable treatments for wrinkles and other signs of aging. It is also used in eye drops, contact lenses, and other medical devices. In addition, it is used in food and beverage products as a stabilizer and thickener. The Sodium Hyaluronate market is highly competitive, with a number of companies offering a range of products. Major players in the market include Allergan, Merck, Sanofi, and Johnson & Johnson. Other companies include BASF, DSM, and Fidia Farmaceutici. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.